Back

A nurse-led intervention improves quality of life and reduces arrhythmic recurrences in patients undergoing atrial fibrillation ablation. Results of the NURSECAT-AF randomized clinical trial.

1 September 2024 (12:00 - 12:15)
Organised by: Logo
Congress Presentation Part of: Nursing and Allied Professions Investigator Awards Advanced Clinical Practice ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Alba Cano Valls

Hospital Clinic of Barcelona, Barcelona (Spain)

3 More presentations in this session

Presentation thumbnail
Impact of agitation status during intensive care on functional outcomes and mortality in patients with cardiovascular disease
Mr S. Soeda (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
Cardiovascular disease history as a predictor for adverse outcomes in frail older adults admitted to acute geriatric settings: 12-month outcomes from an Australian frailty registry.
Doctor J. McDonagh (Wollongong, AU)
Abstract Slides Video
Presentation thumbnail
CARD-SARC: mixed-method study to develop a disease-specific health-related quality of life tool for cardiac sarcoidosis
Mr J. Quijano-Campos (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Nursing and Allied Professions Investigator Awards
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Improving outcomes of atrial fibrillation ablation through integrated personalized lifestyle interventions: preliminary results of a randomized controlled trial
thumbnail
Congress Session
Nursing and Allied Professions Investigator Awards
thumbnail
Congress Session
Late-Breaking Clinical Trials: atrial fibrillation ablation and rhythm control

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources